Tumor Necrosis Factor Inhibitor Drugs Market
1 Introduction to Research & Analysis Reports
1.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Overall Market Size
2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size: 2021 VS 2028
2.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market
3.2 Top Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies Ranked by Revenue
3.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Companies
3.4 Top 3 and Top 5 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market
3.6.1 List of Global Tier 1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Markets, 2021 & 2028
4.1.2 Humira
4.1.3 Enbrel
4.1.4 Remicade
4.1.5 Simponi/Simponi Aria
4.1.6 Cimzia
4.1.7 Biosimilars
4.2 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
4.2.1 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2022
4.2.2 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2023-2028
4.2.3 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2021 & 2028
5.1.2 Rheumatoid Arthritis
5.1.3 Psoriasis
5.1.4 Psoriatic Arthritis
5.1.5 Crohn?s Disease
5.1.6 Ulcerative Colitis
5.1.7 Ankylosing Spondylitis
5.1.8 Juvenile Idiopathic Arthritis
5.1.9 Hidradenitis Suppurativa
5.1.10 Others
5.2 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
5.2.1 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2022
5.2.2 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2023-2028
5.2.3 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2021 & 2028
6.2 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
6.2.1 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2022
6.2.2 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2023-2028
6.2.3 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.3.2 US Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.3.3 Canada Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.3.4 Mexico Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.4.2 Germany Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.3 France Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.4 U.K. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.5 Italy Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.6 Russia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.8 Benelux Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.5.2 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.3 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.4 South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.6 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.6.2 Brazil Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.6.3 Argentina Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.7.2 Turkey Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.7.3 Israel Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.7.5 UAE Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Corporate Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.1.4 AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2017-2022)
7.1.5 AbbVie Inc. Key News
7.2 Amgen Inc.
7.2.1 Amgen Inc. Corporate Summary
7.2.2 Amgen Inc. Business Overview
7.2.3 Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.2.4 Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2017-2022)
7.2.5 Amgen Inc. Key News
7.3 Johnson & Johnson Services, Inc.
7.3.1 Johnson & Johnson Services, Inc. Corporate Summary
7.3.2 Johnson & Johnson Services, Inc. Business Overview
7.3.3 Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.3.4 Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Services, Inc. Key News
7.4 UCB S.A.
7.4.1 UCB S.A. Corporate Summary
7.4.2 UCB S.A. Business Overview
7.4.3 UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.4.4 UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2017-2022)
7.4.5 UCB S.A. Key News
7.5 Novartis International AG
7.5.1 Novartis International AG Corporate Summary
7.5.2 Novartis International AG Business Overview
7.5.3 Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.5.4 Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis International AG Key News
7.6 Pfizer, Inc.
7.6.1 Pfizer, Inc. Corporate Summary
7.6.2 Pfizer, Inc. Business Overview
7.6.3 Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.6.4 Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2017-2022)
7.6.5 Pfizer, Inc. Key News
7.7 Merck & co., Inc.
7.7.1 Merck & co., Inc. Corporate Summary
7.7.2 Merck & co., Inc. Business Overview
7.7.3 Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.7.4 Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global Market (2017-2022)
7.7.5 Merck & co., Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Opportunities & Trends in Global Market
Table 2. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Drivers in Global Market
Table 3. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Restraints in Global Market
Table 4. Key Players of Tumor Necrosis Factor (TNF) Inhibitor Drugs in Global Market
Table 5. Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Type
Table 9. List of Global Tier 1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Inc. Corporate Summary
Table 31. AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 32. AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Inc. Corporate Summary
Table 34. Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 35. Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services, Inc. Corporate Summary
Table 37. Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 38. Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 39. UCB S.A. Corporate Summary
Table 40. UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 41. UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis International AG Corporate Summary
Table 43. Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 44. Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer, Inc. Corporate Summary
Table 46. Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 47. Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Merck & co., Inc. Corporate Summary
Table 49. Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 50. Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Tumor Necrosis Factor (TNF) Inhibitor Drugs Segment by Type in 2021
Figure 2. Tumor Necrosis Factor (TNF) Inhibitor Drugs Segment by Application in 2021
Figure 3. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in 2021
Figure 8. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 12. US Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 24. China Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. UCB S.A. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis International AG Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer, Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & co., Inc. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
